RankAlpha logo
Back to Rankings

GILD

Gilead SciencesB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Bull case: Durable HIV revenue growth, stronger-than-expected adoption of long‑acting therapies (e.g., Cabenuva), and positive late‑stage readouts drive margin expansion and multiple re-rating toward the top analyst target.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +8.4.
What can break
HIV pricing pressure and competitive share loss
Momentum
62
Value
66
Sentiment
61
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $146.84 · Bull $170.00 · Bear $103.00Analysis 2026-02-11; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-02-11 • Model: RankAlpha Sentiment AI
Investment thesis
As of 2026-09-09

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions

Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $159.76
Why
Momentum62 · Δ7d +14.4
Value66 · Δ7d 0.0
Sentiment61 · Δ7d +8.4
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.

Confirming evidence

  • Sentiment remains the lead driver in the composite, 7D delta +8.4.

Contradictions & invalidation

  • HIV pricing pressure and competitive share loss
  • Patent/litigation loss or earlier-than-expected generic entry
  • Bear case: HIV pricing pressure, competitive share losses, or clinical/regulatory setbacks compress multiples and push the stock toward the low analyst target.

Catalyst clock

2026-05-12

Next quarterly results (estimated)

Lead driver: Sentiment · See AI snapshot
Momentum
62
9% active weight
Current posture
7d trendImproving
Δ7d
+14.4
Δ21d
+4.6
Value
66
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.7
Sentiment
61
62% active weight
Current posture
7d trendImproving
Δ7d
+8.4
Δ21d
-0.7
Why this grade

Composite grade B. Momentum 62.1 / Value 65.9 / Sentiment 61.1

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-02-11. Scenario method

B+
Bull case
20%
Probability
Target price
$170.00
Analysis reference price unavailable
Analysis 2026-02-11 · RankAlpha Sentiment AI
Most likely
B
Base case
60%
Probability
Target price
$146.84
Analysis reference price unavailable
Analysis 2026-02-11 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$103.00
Analysis reference price unavailable
Analysis 2026-02-11 · RankAlpha Sentiment AI
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$172.25B
Beta
0.37
Shares Out
1.24B
P/E (TTM)
18.4
P/S (TTM)
5.05
P/FCF (TTM)
28.33
Rev YoY
+10.7%
EPS YoY
-640.7%
Gross Margin
+79.7%
Op Margin
+39.1%
Net Debt
$15.93B
Current Ratio
1.27
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data